Rehab Management: All Press Releaseshttp://www.rehabpub.com/prnewswire/All unedited Press Releasesen-usSun, 14 Mar 2010 14:50 ESTSun, 14 Mar 2010 14:50 ESTACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundationhttp://www.rehabpub.com/press_release.asp?id=10232639Sun, 14 Mar 2010 14:50 ESThttp://www.rehabpub.com/press_release.asp?id=10232639Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010http://www.rehabpub.com/press_release.asp?id=10232638Sun, 14 Mar 2010 13:00 ESThttp://www.rehabpub.com/press_release.asp?id=10232638New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Conditionhttp://www.rehabpub.com/press_release.asp?id=10232635Sun, 14 Mar 2010 12:05 ESThttp://www.rehabpub.com/press_release.asp?id=10232635Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patientshttp://www.rehabpub.com/press_release.asp?id=10232633Sun, 14 Mar 2010 12:00 ESThttp://www.rehabpub.com/press_release.asp?id=10232633NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk Cardiovascular Patients With Impaired Glucose Tolerancehttp://www.rehabpub.com/press_release.asp?id=10232634Sun, 14 Mar 2010 12:00 ESThttp://www.rehabpub.com/press_release.asp?id=10232634PharmMD's Brad Tice to Receive Distinguished Achievement Awardhttp://www.rehabpub.com/press_release.asp?id=10232630Fri, 12 Mar 2010 23:35 ESThttp://www.rehabpub.com/press_release.asp?id=10232630Medica Selects Fairview Pharmacy Services, LLC to Deliver Medication Therapy Management Services to City of Minneapolis Employeeshttp://www.rehabpub.com/press_release.asp?id=10232628Fri, 12 Mar 2010 22:04 ESThttp://www.rehabpub.com/press_release.asp?id=10232628Speakers to Focus on Translating Regenerative Medicine Sciencehttp://www.rehabpub.com/press_release.asp?id=10232627Fri, 12 Mar 2010 17:15 ESThttp://www.rehabpub.com/press_release.asp?id=10232627Reportlinker Adds Global Stem Cells Research Industryhttp://www.rehabpub.com/press_release.asp?id=10232617Fri, 12 Mar 2010 15:58 ESThttp://www.rehabpub.com/press_release.asp?id=10232617Reportlinker Adds Global Spinal Surgery Devices: Market Analysis and Opportunity Assessmenthttp://www.rehabpub.com/press_release.asp?id=10232616Fri, 12 Mar 2010 15:54 ESThttp://www.rehabpub.com/press_release.asp?id=10232616Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systemshttp://www.rehabpub.com/press_release.asp?id=10232615Fri, 12 Mar 2010 13:30 ESThttp://www.rehabpub.com/press_release.asp?id=10232615Aethlon Medical to Present at The Salk Institutehttp://www.rehabpub.com/press_release.asp?id=10232604Fri, 12 Mar 2010 13:00 ESThttp://www.rehabpub.com/press_release.asp?id=10232604AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthmahttp://www.rehabpub.com/press_release.asp?id=10232597Thu, 11 Mar 2010 22:03 ESThttp://www.rehabpub.com/press_release.asp?id=10232597FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancerhttp://www.rehabpub.com/press_release.asp?id=10232596Thu, 11 Mar 2010 21:15 ESThttp://www.rehabpub.com/press_release.asp?id=10232596Trubion to Present Company Overview and Participate in Panel Discussion at Prestigious Life Science Innovation Northwest 2010http://www.rehabpub.com/press_release.asp?id=10232595Thu, 11 Mar 2010 21:00 ESThttp://www.rehabpub.com/press_release.asp?id=10232595Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancerhttp://www.rehabpub.com/press_release.asp?id=10232594Thu, 11 Mar 2010 20:08 ESThttp://www.rehabpub.com/press_release.asp?id=10232594Volcano Announces Activities at the ACC 2010http://www.rehabpub.com/press_release.asp?id=10232593Thu, 11 Mar 2010 20:00 ESThttp://www.rehabpub.com/press_release.asp?id=10232593bioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Toolhttp://www.rehabpub.com/press_release.asp?id=10232585Thu, 11 Mar 2010 19:03 ESThttp://www.rehabpub.com/press_release.asp?id=10232585Stimuvax Will Become Decision Resources' Proprietary Clinical Gold Standard For The Treatment Of Locally Advanced Non-Small-Cell Lung Cancerhttp://www.rehabpub.com/press_release.asp?id=10232575Thu, 11 Mar 2010 15:30 ESThttp://www.rehabpub.com/press_release.asp?id=10232575Azur Pharma Announces the Signing of a Definitive Agreement to Acquire PRIALT(R) From Elanhttp://www.rehabpub.com/press_release.asp?id=10232574Thu, 11 Mar 2010 15:19 ESThttp://www.rehabpub.com/press_release.asp?id=10232574